Skip to main content
    O

    Oscar Health Inc (OSCR)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $31.33
    +0.28 (+0.90%)

    Market Cap: $9.65B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Oscar Health Inc (OSCR) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Oscar Health (OSCR) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Oscar Health reported EPS of $0.49, above the -$0.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    50%(12/24)
    Avg Surprise
    +21.69%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.12
    Range-$1.21 - -$1.03
    14 analysts
    Revenue Consensus
    $4.61B
    Range$4.39B - $4.81B
    12 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$2.27
    Range$1.81 - $2.76
    4 analysts
    EPS Revisions
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$2.21+2.3%
    60d ago$2.21+2.3%
    30d ago$2.21+2.7%
    7d ago$2.25+0.6%
    Current$2.27
    Revenue Consensus
    $5.52B
    Range$5.04B - $5.85B
    5 analysts

    Next Report

    OSCR has an expected report date of Feb 8, 2027.

    OSCR Earnings Call

    The latest OSCR earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 24 quarters below that had an estimate, OSCR beat 12 and missed 12. Revenue for the quarter ended Sep 30, 2026 was $5.14B, up 71.9% from $2.99B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.49-$0.11-$0.40 - $0.07+545.45%BeatN/A74 up, 1 downNov 5, 2026$5.14B
    Jun 30, 2026$1.10$0.43-$0.18 - $0.66+155.81%BeatN/A103 up, 1 downAug 6, 2026$4.88B
    Mar 31, 2026$2.07$1.10$0.26 - $1.75+88.18%Beat+125.0%73 up, 1 downMay 6, 2026$4.65B
    Dec 31, 2025-$1.24-$0.92-$1.07 - -$0.83-34.78%MissN/A85 up, 1 downFeb 10, 2026$2.81B
    Sep 30, 2025-$0.53-$0.58-$0.96 - -$0.40+8.62%BeatN/A70 up, 3 downNov 6, 2025$2.99B
    Jun 30, 2025-$0.89-$0.84-$0.90 - -$0.74-5.95%Miss-545.0%30 up, 3 downAug 6, 2025$2.86B
    Mar 31, 2025$0.92$0.81$0.67 - $1.03+13.58%Beat+48.4%41 up, 1 downMay 7, 2025$3.05B
    Dec 31, 2024-$0.62-$0.58-$0.68 - -$0.48-6.90%MissN/A52 up, 3 downFeb 4, 2025$2.39B
    Sep 30, 2024-$0.22-$0.18-$0.23 - -$0.05-22.22%MissN/A70 up, 0 downNov 7, 2024$2.42B
    Jun 30, 2024$0.20$0.16$0.12 - $0.19+25.00%BeatN/A61 up, 0 downAug 7, 2024$2.22B
    Mar 31, 2024$0.62$0.27$0.22 - $0.33+129.63%BeatN/A50 up, 0 downMay 7, 2024$2.14B
    Dec 31, 2023-$0.66-$0.70-$0.74 - -$0.69+5.71%BeatN/A40 up, 0 downFeb 7, 2024$1.43B
    Sep 30, 2023-$0.29-$0.47-$0.57 - -$0.43+38.30%BeatN/A50 up, 0 downNov 7, 2023$1.44B
    Jun 30, 2023-$0.07-$0.16-$0.43 - -$0.03+56.25%BeatN/A41 up, 0 downAug 8, 2023$1.52B
    Mar 31, 2023-$0.18-$0.09-$0.10 - $0.02-100.00%MissN/A40 up, 0 downMay 9, 2023$1.47B
    Dec 31, 2022-$1.05-$1.19-$1.41 - -$0.78+11.76%BeatN/A50 up, 0 downFeb 9, 2023$995.13M
    Sep 30, 2022-$0.91-$0.69-$0.80 - -$0.63-31.88%MissN/A60 up, 0 downNov 8, 2022$978.43M
    Jun 30, 2022-$0.53-$0.35N/A-51.43%MissN/AN/A0 up, 1 downAug 11, 2022$1.02B
    Mar 31, 2022-$0.36-$0.12-$0.45 - -$0.02-200.00%MissN/A60 up, 0 downMay 10, 2022$972.76M
    Dec 31, 2021-$0.95-$0.73-$1.16 - -$0.73-30.14%MissN/A5N/AFeb 10, 2022$496.07M
    Sep 30, 2021-$1.02-$0.65-$0.69 - -$0.60-56.92%MissN/A4N/ANov 10, 2021$443.98M
    Jun 30, 2021-$0.35-$0.47-$0.53 - -$0.41+25.53%BeatN/A5N/AAug 12, 2021$529.28M
    Mar 31, 2021-$0.75-$0.54N/A-38.89%MissN/AN/AN/AMay 13, 2021$369.39M
    Dec 31, 2020-$1.22-$1.17N/A-4.27%MissN/AN/AN/AMar 4, 2021$187.63M
    Last 24 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.74, after -$0.02 the year before. It was -$1.22 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.74N/A
    Dec 31, 2024-$0.02N/A
    Dec 31, 2023-$1.20N/A
    Dec 31, 2022-$2.85N/A
    Dec 31, 2021-$3.07N/A
    Dec 31, 2020-$1.22N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 13 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,22513
    2026Q2Jun 30, 20265,76815
    2026Q1Mar 31, 20265,05213
    2025Q4Dec 31, 20257,67813
    2025Q3Sep 30, 20256,75213
    2025Q2Jun 30, 20254,5039
    2025Q1Mar 31, 20254,45812
    2024Q4Dec 31, 20245,46910

    2026Q3 Earnings Call

    Opening remarks

    Mark Bertolini CEO Address consumer needs, including opportunities created by competitor exits. These strengths, combined with our medical cost management, operating efficiency, and superior technology, will drive sustainable financial performance in 2027 and beyond. Now I will review our business highlights. Oscar Insurance ended the third quarter with 2.7 million members, up 27% year-over-year. We are entering open enrollment with a 24% larger footprint spanning 713 counties. We are also expanding into South Carolina. Our expansion increases our total addressable market to approximately 10 million consumers across 21 states. Oscar is launching a new wave of consumer lifestyle products. Our newest product, RetireEase, is live in select markets and serves a growing segment of 2.5 million early retirees in the ACA. Members keep their trusted doctors and receive set prices for preventive services, physical therapy, and heart, bone, and joint care. We are also addressing affordability through bundled benefits. Hundreds of Oscar plans now include dental and vision coverage. In addition, our new Allstate Health Solutions partnership pairs Oscar plans with low-cost supplemental coverage to help bronze members manage out-of-pocket costs. Each product meets a distinct consumer need and extends our reach into high-value, underserved segments. Our Oscar team is also scaling CHOICE. Our Hy-Vee Health with Oscar product is expanding from Iowa into Nebraska, Missouri, and Kansas. This product's concierge care model earns a 92% satisfaction rate and can now serve more small businesses, part-time employees, and gig workers. We are also launching HelloMeno off-exchange to better serve women across the workforce. Employer demand is building. CHOICE adoption is growing fastest in health care, technology, construction, and manufacturing sectors across Oscar states. Oscar's health technology puts consumers in control of their health care decisions across two platforms. The Oscar platform now includes new AI capabilities that make our product suite easy to understand. The Lucie platform serves the broader market, personalizing the health care shopping experience at scale. Lucie instantly matches consumers with plans from major ACA carriers and select supplemental carriers and guides brokers through CMS eligibility. No other platform brings these capabilities together in one place. Lucie is on track to sell approximately 800,000 new policies in 2027, driven by growing broker and consumer demand. Oscar Health's third-quarter performance puts us on track to deliver strong results one year ahead of plan. Our disciplined pricing, product innovation, and technology-powered support are delivering superior member experiences and efficiency across the company. The individual market opportunity is growing. People expect health care to work like the best consumer products: simple, transparent, and personalized. We are building a consumer health care company that meets those expectations and serves a much larger market. The team is positioned to grow market share.

    Frequently Asked Questions About OSCR

    When is Oscar Health's next earnings date?

    Oscar Health's next earnings report is expected for Feb 8, 2027.

    Did OSCR beat earnings estimates last quarter?

    Yes. Oscar Health reported EPS of $0.49 for the quarter ended Sep 30, 2026, above the -$0.11 estimate, a 545.45% surprise.

    What EPS do analysts expect from OSCR next quarter?

    The consensus EPS estimate for Oscar Health for the quarter ending Dec 31, 2026 is -$1.12 from 14 analysts, with estimates from -$1.21 to -$1.03.

    How often does OSCR beat earnings estimates?

    Oscar Health beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +95.50%.